Biomarkers

R&D

Research has demonstrated that some individuals at elevated risk of Alzheimer's disease can be identified before symptoms emerge.

R&D

The Parkinson's disease field is increasingly moving toward biologically defined disease frameworks using molecular biomarkers.

News

A new R&D project will try to develop assays for LRRK2, a biomarker linked to Parkinson's that has emerged as a major drug target in the disease.

News

Advances in therapeutics are outpacing the development of diagnostics due to policy and payment barriers, holding back effective, targeted care.

News

An international trial has started to see if a simple finger-prick blood test could predict Alzheimer's before symptoms start.

News

ESMO guidance on the validation and clinical use of AI-based biomarkers in oncology aims to strike a balance between caution and over-reliance.